US/UK/Canada

Share

About Us

Reportbuyer.com is the intelligent way to find and buy business information products. We serve all sizes of companies, from the early stage start-up to global corporations across all sectors and markets.

Quotes

It means that we can offer our customers a study on almost every company, country or market area
Edwin Bailey
Pick a time period -
Tags ( Active)

Combination Therapies Could be the Future of Cancer Treatment says New Report

ReportBuyer.com the leading website for market research reports has added a new study Multi-Targeted Therapies - New Wave of Combination Therapies in Late Stage Development for Lung Cancer Offer Promise . The report provides an overview of the discovery and development of therapeutic drug combinations and multi-target drugs for oncology. The report provides an insight into different methods and techniques used to identify and design drugs that act upon multiple targets in the treatment of cancer.

Combination therapies could be the future of cancer treatment says new report

Reportbuyer.com has added a new report to it’s catalogue, "Multi-Targeted Therapies - New Wave of Combination Therapies in Late Stage Development for Lung Cancer Offer Promise" , this research provides an overview of the discovery and development of therapeutic drug combinations and multi-target drugs for oncology. The 55 page report states that there is a wave of combination therapies in late stage development that have the potential to revolutionize long-term oncological treatment by addressing the

Breast cancer therapy: 10 products to dominate market by 2017 says new report

‘Breast Cancer Drug Discoveries: What the future holds’The report ‘Breast Cancer Drug Discoveries: What the future holds (%20http:/www.pharmaceutical-market-research.com/publications/drug_discovery/breast_cancer_drug_discoveries_future_holds_2008.html)’ states that key therpeutic brands achieved sales of US$12.7 billion in 2010, with growth due to higher sales for a number of treatments rather than the launch of new products. In 2010, nearly 50% of breast cancer sales were due to three branded targeted therapies. With a large unmet clinical need, further agents are necessary to increase

There are no items matching the current filter
There are no more items matching the current filter
Back to top